by In2Pharma | Dec 27, 2024 | News
The Netherlands Patients with severe conditions who have no access to approved medicinal products can receive treatment through a Compassionate Use Program (CUP). The Medicines Evaluation Board (MEB) has published new policy guidelines for the implementation of these...
